Magnesol

Quick links to important sections

Magnesol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Magnesol

Property Description
Active Ingredients Magnesium Sulfate, Dextrose
Form Sterile Solution for Intravenous Injection/Infusion
Pharmacological Class Electrolyte Replenisher, Miscellaneous Anticonvulsant
Common Use Corrects Magnesium deficiency (Hypomagnesemia)
Origin Combination of Synthetic (Sulfate) and Derived (Dextrose)

What Type of Medicine is Magnesol and What is Its Purpose?

Magnesol is a combination medicinal product, specifically a sterile, nonpyrogenic solution developed for intravenous (IV) administration. It functions primarily as an Electrolyte Replenisher and Mineral Supplement, and is classified within the broader category of miscellaneous anticonvulsants. This preparation's fundamental purpose is to rapidly restore critical systemic balance by correcting acute magnesium deficiency (hypomagnesemia). Its IV solution form is selected specifically for scenarios requiring immediate therapeutic action; this injection contains magnesium to help manage serious conditions related to the loss of this essential electrolyte.


Magnesol's Composition: Active Ingredients and Drug Form

The solution contains two active ingredients: Magnesium Sulfate and Dextrose (D-glucose). Magnesol is exclusively prepared as an Intravenous Injection/Infusion Solution. The therapeutic compound is the Magnesium Sulfate, a synthetic compound that provides the active magnesium ion (Mg^2+). The secondary component, Dextrose, is included as a stabilizing carbohydrate source and aqueous vehicle to ensure the solution's compatibility and safety for direct infusion into the bloodstream, distinguishing it from non-intravenous mineral salts.


The Fundamental Benefit of the Magnesium Ion

The primary benefit of this medicine stems from the physiological action of the magnesium ion, which helps regulate neuromuscular transmission and muscle excitability. This regulatory role of magnesium makes it valuable for controlling states of hyper-excitability. Magnesium plays a critical role in calming nerve impulses. The direct IV solution ensures the necessary therapeutic concentration is achieved quickly, which is critical for restoring the essential mineral deficit and providing a stabilizing effect on the nervous system during acute events.

Regulatory References

  1. NIH Fact Sheet for Health Professionals

What side effects are possible with Magnesol?

Possible Side Effects and Safety Information

The safety profile of Magnesol (Magnesium Sulfate in Dextrose Injection) is principally governed by the risk of magnesium intoxication, known medically as hypermagnesemia, which is directly related to the concentration of magnesium in the body.

Adverse reactions are classified in regulatory documents according to the affected system-organ classes and the severity of the magnesium excess.

Documented Adverse Reactions and Systemic Effects

Adverse effects are categorized by the official labeling and often represent a progression of toxicity, affecting multiple body systems:

  • Nervous System Disorders: Manifestations can include central nervous system (CNS) depression, lethargy, somnolence, slurred speech, and diminished or absent deep tendon reflexes.
  • Vascular and Cardiac Disorders: Common early signs of toxicity may involve flushing and sweating. More significant effects include hypotension (low blood pressure), bradycardia (slowed heart rate), and, in severe cases, circulatory collapse.
  • Respiratory, Thoracic and Mediastinal Disorders: The most serious, documented adverse reactions related to magnesium intoxication include respiratory depression and potentially life-threatening respiratory paralysis.

Serious Adverse Reactions and Restrictions

Official prescribing information documents specific, clinically important adverse reactions that require cautious use. These include the risk of cardiac arrest and heart block in individuals with existing myocardial damage. For this reason, the medicine is contraindicated in patients with pre-existing heart block.

Population-Specific Safety Considerations are detailed in regulatory documents:

  • Patients with Renal Impairment face a significantly higher risk of magnesium toxicity, as the kidneys are solely responsible for its excretion. Use is constrained in those with severe kidney dysfunction.
  • Pregnant Patients: Continuous administration beyond five to seven days is specifically associated in official labeling with documented potential for fetal harm, including hypocalcemia and skeletal abnormalities like neonatal fracture.

Overdose and Emergency Response

Overdosage with Magnesol, resulting in severe hypermagnesemia, is characterized by specific clinical manifestations documented in regulatory labeling. Intoxication initially presents with signs of systemic depression, including sharp hypotension (drop in blood pressure), flushing, sweating, generalized weakness, and CNS depression. A key clinical sign indicating severe overexposure is the disappearance of the patellar reflex.

Severe toxicity can rapidly escalate, leading to life-threatening cardiorespiratory outcomes. These officially documented complications include respiratory paralysis, severe heart block, and cardiac arrest. Regulatory documents note that serum magnesium concentrations in excess of 12 mEq/L may be fatal. Patients with renal impairment are at a significantly increased risk due to impaired clearance.

The administration of Magnesol must be immediately discontinued upon suspected overdosage. Urgent medical attention must be sought immediately, as official protocols mandate the availability and administration of an injectable calcium salt, such as Calcium Gluconate, which acts as the official counteracting agent. Management may also require artificial ventilation if respiratory function is compromised, and hemodialysis for the most severe cases or those involving renal failure.

Therapeutic Uses of Magnesol

What Magnesol Treats: Main Uses and Benefits

Magnesol is commonly used in situations involving certain distressing symptoms related to systemic imbalance and symptoms that create noticeable physiological strain. Magnesium compounds are often used to address symptoms that interfere with daily functioning. Its application is relevant in contexts marked by increased discomfort or tension, and helps support general well-being during symptomatic phases.

It is applied across domains where additional symptomatic support is needed, primarily addressing symptoms associated with acute or episodic changes and those linked to organ-specific functional stress. For instance, it is relevant for managing symptom clusters that may become intense or disruptive in conditions involving episodic or fluctuating manifestations.

This medication is often applied in clinical scenarios when symptoms of heightened physiological activity become temporarily overwhelming. It is commonly used when short-term symptomatic assistance is needed, and contributes to easing the overall symptom load.


Quick Fact: Support for Episodic Discomfort

It is used for managing groups of symptoms that appear suddenly or fluctuate, providing support during phases of increased distress where short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus overview of Magnesium Oxide

Eligibility and Restrictions for Use

Magnesol eligibility is strictly governed by patient health status, particularly cardiac and renal function. The medicine is contraindicated and must not be used in populations diagnosed with heart block, myocardial damage, diabetic coma, or myasthenia gravis. This exclusion also applies to individuals with severe renal insufficiency due to the high risk of magnesium accumulation and toxicity.

Eligibility-Related Restrictions

Use is restricted and requires caution in several populations. Patients with any degree of renal impairment must be closely monitored for magnesium levels and may require a reduced dosage. Because the solution contains Dextrose, caution is necessary for those with diabetes mellitus or prediabetes due to the risk of elevated blood glucose. For geriatric patients, dosage adjustments are often needed due to the common reduction in kidney function.

For pregnant women, continuous administration beyond five to seven days is not recommended due to official regulatory concern over potential fetal bone abnormalities. Use is strictly prohibited within the two hours immediately preceding delivery. Use in nursing women should also proceed with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation for Magnesol (Magnesium Sulfate in Dextrose Injection, USP) focuses on interactions resulting from additive pharmacodynamic effects and altered magnesium clearance.


Documented Interaction Patterns

Interaction Type Interacting Products / Categories
Pharmacodynamic Potentiation CNS Depressants (Narcotics, Hypnotics, Anesthetics), Neuromuscular Blocking Agents, Dihydropyridine Calcium Channel Blockers.
Exposure Modification Drugs that induce magnesium loss (e.g., Diuretics, Aminoglycosides, Cisplatin), Alcohol.

Official Interaction Statements and Restrictions

Co-administration with CNS Depressants may result in additive CNS depressant effects, and combining with Neuromuscular Blocking Agents can cause the potentiation and prolongation of neuromuscular blockade, as noted in prescribing information. The use of agents such as certain Diuretics or Aminoglycosides is documented to increase the renal clearance of magnesium, leading to reduced systemic exposure.

Physical Incompatibility is a key restriction: Salicylates and Alkali Carbonates must not be administered in the same intravenous line due to the documented risk of precipitation. Furthermore, the official label notes that Renal Impairment heightens the risk of magnesium intoxication, which, in turn, increases the clinical significance of all documented pharmacodynamic interactions.

Mechanism of Action

How Magnesol Works

The mechanism of Magnesol (Magnesium Sulfate) is governed entirely by the Magnesium Ion ( Mg^2+), which functions as a fundamental physiological antagonist to calcium ( Ca^2+) across excitable tissues. This action directly targets and modulates excessive signaling within the central and peripheral nervous systems, as well as the vascular system.

Modulation of Central and Peripheral Excitability

The Mg^2+ ion regulates neuronal signaling by acting as a voltage-dependent blocker of the NMDA receptor, a primary mediator of excitatory impulses in the central nervous system. By limiting the ion flow through this channel, the mechanism dampens high-frequency electrical activity, leading to the observed depression of nerve impulse generation.

Regulation of Neuromuscular and Vascular Tone

At the neuromuscular junction, Mg^2+ restricts the presynaptic release of the neurotransmitter acetylcholine ( ACh) by competitively inhibiting the necessary influx of Ca^2+ ions. This reduction in ACh output decreases the excitability of skeletal muscle fibers. Concurrently, the ion acts as a calcium channel antagonist on vascular smooth muscle, preventing the Ca^2+ rise required for contraction, which leads to peripheral vasodilation and relaxation of the vessel walls.

Dosage and Administration Information

How Magnesol is Used: Official Dosing and Administration

Magnesol (Magnesium Sulfate Injection) is used exclusively under medical supervision, following strict protocols outlined in regulatory documentation. This section details the proper administration route, dosing regimens, and procedural requirements for its use.


Administration Route and Preparation

Magnesol is administered primarily via Intravenous (IV) infusion. For specific regimens, Intramuscular (IM) injection may be utilized. Solutions supplied in pre-mixed bags are ready for use and do not require further dilution. However, concentrated Magnesium Sulfate solutions must be diluted to a concentration of 20% or less prior to IV infusion.


Standard Dosing and Frequency

Dosing is highly controlled, typically consisting of a quick initial dose followed by a slower maintenance phase. Administration rates are strictly limited; for hypomagnesemia, the IV infusion rate generally should not exceed 1 gram per hour.

Regimen Dose and Administration Detail
IV Loading Dose (Acute Use) Typically 4 to 6 grams administered over a short period.
IV Maintenance Dose 1 to 2 grams per hour via continuous infusion.

Procedural and Time-Based Instructions

Treatment duration is often short, with administration for acute conditions, such as eclampsia, generally continued for 24 hours after the last seizure or delivery. Dosage adjustment is mandatory for certain populations:

  • Renal Impairment: Doses must be reduced. The maximum recommended dosage for patients with severe renal impairment is 20 grams over 48 hours.
  • Procedural Condition: Administration must be carried out using an intravenous infusion pump, and urine output must be maintained at 100 mL during the four hours preceding each dose.

Recent Clinical Evidence

Magnesol: Recent Clinical Evidence

Research has explored the use of the magnesium sulfate intravenous solution in the context of specific acute conditions. The findings describe patterns observed in the populations studied and do not provide predictions for individual responses.


Research Evidence for Correcting Acute Magnesium Deficiency

Magnesol was evaluated in research exploring temporary physiological imbalance caused by low magnesium levels (hypomagnesemia). This research primarily relies on observational settings and foundational evidence. Studies monitored outcomes related to systemic or functional imbalance, such as changes in the concentration of magnesium in the blood. Findings indicate that replacement therapy was associated with the measurement of normal serum magnesium levels and changes observed in deficiency-related signs.


Evidence from Trials in Pregnancy-Related Conditions

Magnesol was studied for two major acute conditions in pregnant women. These studies primarily focused on outcomes related to episodic or acute changes.

  • Seizure Prevention: Large-scale Randomized Controlled Trials (RCTs) examined outcomes related to seizure occurrence in women diagnosed with severe preeclampsia or active eclampsia. Findings describe patterns observed in the studies where the groups receiving the IV solution had measured differences in the rate of seizure occurrence compared to control groups. Studies provide limited information for long-term outcomes for women beyond the immediate post-delivery period.

  • Fetal Neuroprotection: Major placebo-controlled RCTs included long-term follow-up to explore whether the use of the magnesium sulfate IV solution in women at high risk of imminent preterm delivery was associated with differences in the infant’s neurological outcomes. Data show patterns related to measured differences in the rates of cerebral palsy in the groups studied; however, the results regarding the overall combined outcome of death or cerebral palsy were mixed. Long-term effects are not fully established beyond the primary assessment point.


What Remains Uncertain About the Research

The evidence gaps include: Comparative evidence is lacking concerning the optimal long-term strategy following the initial acute correction of magnesium deficiency. Additionally, findings were mixed regarding the influence of the treatment on hospital admission rates for acute asthma exacerbations, indicating that certainty remains low on this specific, clinically relevant outcome.

Key Studies & References Hypomagnesemia (MSD Manual Professional Edition)

Frequently Asked Questions (FAQ)

Common questions about Magnesol (FAQ)


Q: How long does it typically take to feel the described effects of Magnesol?

Magnesol is administered intravenously, and the desired therapeutic concentration is generally achieved rapidly, with the specific timing determined by the strict administration protocol utilized. The magnesium ion, which provides the therapeutic effect, is cleared primarily by the kidneys and generally has a half-life of around 4 hours.


Q: Can Magnesol cause stomach upset or diarrhea?

Official documentation for the intravenous formulation of Magnesol focuses on adverse reactions related to magnesium toxicity, such as flushing, low blood pressure, and central nervous system effects. Stomach upset or diarrhea are not typically listed among the primary adverse reactions for this injection formulation.


Q: Can Magnesol be used alongside vitamins or other supplements?

Regulatory documents primarily caution against co-administering Magnesol with certain medicines that may increase central nervous system depression or affect magnesium clearance. While specific interactions with general vitamins or supplements are not widely detailed in official prescribing information, it is important to note that the administration of other products in the same intravenous line is generally avoided by medical staff due to the potential for physical incompatibility.


Q: Why might Magnesol be used for purposes other than the main described use?

The official product labeling indicates primary uses for acute magnesium deficiency and seizure prevention in eclampsia. However, authoritative bodies like the World Health Organization also note its study and use in pregnant women at high risk of imminent preterm birth for its potential role in fetal neuroprotection.


Q: Are there any long-term research studies available on Magnesol?

Official warnings note that continuous administration of the medicine in pregnant women beyond five to seven days is associated with the potential for fetal harm, including bone abnormalities. This indicates that long-term use is not established or generally recommended by regulatory authorities.


Q: What is the general expectation for the duration of Magnesol's effects?

The duration of the therapeutic effects relates to how quickly the magnesium is cleared from the body, which has a reported half-life of approximately 4 hours. For acute medical conditions like eclampsia, clinical protocols often mandate continuous treatment for a set duration, such as 24 hours after the last event.


Q: Is it common to feel drowsy after taking Magnesol?

Regulatory documents list central nervous system (CNS) depression as a possible adverse reaction related to magnesium excess. Signs of this condition, which is caused by high levels of magnesium, may include lethargy and somnolence (drowsiness).


Q: Are there any specific foods or drinks that should be avoided when using Magnesol?

Official labeling requires patients to inform their healthcare providers about regular use of alcohol or caffeine drinks, as these can be factors that may affect how the medicine works. However, the prescribing information does not generally list specific foods or non-alcoholic beverages that must be avoided due to direct interaction with the injection.


Q: Will Magnesol affect the results of blood tests?

Yes. Regulatory protocols require close monitoring of serum magnesium concentrations in the blood to guide treatment and ensure safe dosing. Therefore, the administration of Magnesol is expected to change the measured level of magnesium in the blood.


Q: Do older adults need to adjust their use of Magnesol?

Official labeling advises that reduced dosages are often necessary for older adults. This is due to the common age-related reduction in kidney function, as the kidneys are solely responsible for clearing the magnesium from the body.


Q: Does Magnesol interact with common over-the-counter pain relievers?

Regulatory documents explicitly forbid combining aspirin (a Salicylate) in the same intravenous line because of physical incompatibility. Additionally, caution may be necessary with NSAIDs, as their potential to affect kidney function could influence magnesium clearance.


Q: Is there a maximum length of time Magnesol is typically used for?

While treatment for acute conditions is often short, the FDA specifically advises against continuous administration in pregnant women beyond five to seven days due to the documented potential risk of fetal harm.


Q: Is it true that Magnesol is described as having better absorption?

Magnesol is a sterile solution administered directly into the bloodstream via injection or infusion. This route bypasses the entire digestive system, ensuring rapid and complete systemic availability without relying on gastrointestinal absorption.


Q: What are the most common reported reasons people start using Magnesol?

The official product labeling states that the medicine is indicated for the treatment of acute hypomagnesemia (severe magnesium deficiency) and for the prevention and control of seizures associated with eclampsia.


Q: Does Magnesol interact with caffeine or energy drinks?

Regulatory materials advise patients to inform their doctor about regular caffeine intake, including energy drinks, as the caffeine can be a factor that may affect the body's response to the injection.


Q: Are there different forms of Magnesol available (e.g., tablet, liquid)?

Magnesol is available exclusively as a sterile solution intended for intravenous (IV) injection or infusion. It is not available in oral forms such as tablets or standard liquid supplements.


Q: Does alcohol use affect how Magnesol works in the body?

Yes, official documentation notes that alcohol use is associated with increased renal clearance of magnesium. This means that alcohol can lead to reduced systemic exposure of the magnesium ion in the body.


Q: Is Magnesol described as a 'slow-release' formulation?

No. Magnesol is designed for immediate intravenous administration, often utilizing a quick initial dose followed by a continuous infusion to rapidly achieve and maintain therapeutic levels, which is distinct from a slow-release formulation.


Q: Does Magnesol interact with medicines for acid reflux or heartburn?

Certain antacids and Proton-Pump Inhibitors (PPIs) may affect the level of magnesium in the body. Because of this, caution and close monitoring of magnesium levels may be necessary when these medicines are used alongside Magnesol.


Q: Can individuals with diabetes use Magnesol safely?

The medicine is contraindicated for use in patients experiencing diabetic coma. Additionally, because the solution contains Dextrose (a form of sugar), its use for individuals with diabetes requires caution and careful monitoring of blood glucose levels.


Q: Is there any official information on Magnesol use during breastfeeding?

Regulatory materials state that the use of the medicine in nursing women is a decision that requires caution by healthcare providers. This caution is due to the potential for the medicine to pass into breast milk.


Q: How quickly does Magnesol leave the system after the last use?

The magnesium ion is cleared primarily by the kidneys. Pharmacokinetic data indicates that the drug has a reported elimination half-life of approximately 4 hours.


Q: Are there any known interactions between Magnesol and herbal products?

The FDA label requires patients to report all products, including herbal products, to their doctor before administration. While the prescribing information does not list specific, widely documented interactions, the official label emphasizes the importance of the clinical team being fully aware of all products a patient is using.


Q: Does Magnesol cause any issues with driving or operating machinery?

Official product information states that there are no known direct effects of Magnesol on the ability to drive or use machines. However, because adverse effects can include central nervous system depression, if a patient has concerns about driving or operating machinery, the official product information recommends discussing this with a medical professional.


Q: Does Magnesol interact with common antidepressants or anxiety medicines?

Yes. Regulatory documents list Central Nervous System (CNS) Depressants, such as certain narcotics and hypnotics, as interacting due to the risk of additive CNS depressant effects. This category may include certain medicines used to treat anxiety or depression.


Q: Can Magnesol be taken by people who are lactose intolerant or have celiac disease?

The sterile injection solution contains Magnesium Sulfate and Dextrose (glucose) dissolved in water. The composition, as listed in the prescribing information, does not contain lactose or gluten-derived components.


Q: What is the difference between the main and secondary uses of Magnesol?

The main uses are those specifically listed in the regulatory indications, such as treating acute hypomagnesemia and eclampsia seizures. Secondary uses refer to conditions where the medicine may be used according to clinical practice guidelines or research (like fetal neuroprotection), but which may not be an official, FDA-labeled indication.


Q: Does official information clarify how Magnesol impacts mineral levels in the body?

Yes. Official documentation warns that prolonged administration of Magnesol can lead to a documented potential for fetal harm, including hypocalcemia (low calcium levels) and skeletal abnormalities.

How should Magnesol be stored and disposed of?

Official Storage and Disposal Instructions

Official regulatory documents define strict conditions for storing and disposing of Magnesium Sulfate Injection, USP.

Mandatory Storage Conditions

  • Temperature: Store at Controlled Room Temperature, maintained between 20 C to 25 C (68 F to 77 F).
  • Protection: The product must be protected from freezing. Exposure to temperatures above 25 C should be avoided, particularly for solutions in flexible plastic containers.
  • Handling: Before use, the solution must be visually inspected for particulate matter or discoloration and should not be administered if the container seal is compromised or damaged.

Stability and Disposal Rules

  • Stability: Use the solution only if it is clear.
  • Disposal: Any portion of the drug remaining in a single-dose container after administration must be discarded immediately. Unused containers should be kept closed until the moment of use.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Magnesol found in:

A-Z Index: